Outpatient gatifloxacin therapy and dysglycemia in older adults
about
Canadian clinical practice guidelines for acute and chronic rhinosinusitis.Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)Antituberculosis therapy for 2012 and beyondEpidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella InfectionsEmergency department visits for antibiotic-associated adverse eventsA multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in VietnamTherapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensisCholinesterase inhibitors and hospitalization for bradycardia: a population-based studyProton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control studyRoad trauma in teenage male youth with childhood disruptive behavior disorders: a population based analysisMedication-induced diabetes mellitus.Bitter taste receptors influence glucose homeostasisUse of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever.Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort studyMoxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trialInfluences on the start, selection and duration of treatment with antibiotics in long-term care facilities.A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese childrenExtended-release nifedipine and the risk of intestinal obstruction: a population-based study.Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.Policy alternatives for treatments for rare diseases.Risks associated with the therapeutic use of fluoroquinolones.A study on drug safety monitoring program in India.The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockersA population-based study of the drug interaction between proton pump inhibitors and clopidogrelFluoroquinolones and collagen associated severe adverse events: a longitudinal cohort studyFour-month moxifloxacin-based regimens for drug-sensitive tuberculosisGatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trialTrimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.New regimens for reducing the duration of the treatment of drug-susceptible pulmonary tuberculosis.Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study.Moxifloxacin in the treatment of skin and skin structure infections.Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study.Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agentsA population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.Variability in antibiotic use at children's hospitals.Identifying geographical regions serviced by hospitals to assess laboratory-based outcomes.Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.A secure distributed logistic regression protocol for the detection of rare adverse drug eventsCorrelation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis.
P2860
Q21245393-6B96661F-DD6C-4EB8-953C-E169F63B171BQ24236124-404AB556-FBA1-492A-B7DE-EC74A41C2513Q26829101-BB644DFD-348F-453D-9EFC-07AEFF8A65E0Q28084595-2A91526A-FE0A-49E6-A2F4-76AF9A8FBC29Q28290501-66C80BAE-C0E8-460F-AD33-841589841ED1Q28472731-9A1A8363-02D6-4955-9D87-8AD19C4EDC21Q28473696-56053E97-2D77-41CB-B70B-F5AA8EC280E2Q28476190-6844AABF-19EA-4096-8EA5-76B2309A15E0Q28543390-B7B6F29B-50B7-4B13-8EF9-6CA6601D459DQ28748446-013BDB31-1F1F-4812-AF90-15B052AB5FD7Q30276191-6C925434-1985-49E7-9537-4C15B96A4E55Q30855188-305DA37D-18E4-4D39-8681-8A3B2524B48EQ33161031-5D938519-A921-4451-9CA0-46699FAF31D8Q33288953-E3C2BD9F-CB6D-4E37-B5EC-E1F01537F161Q33634928-DFAB0B5C-298E-4F23-96AF-2FB9830E6F7AQ33837706-C5954DC0-B3BE-4A0E-B7C3-22598DE977ECQ33848870-DF30E996-D002-42C1-B181-3DCC1731E2F1Q33988931-3F86871B-A20D-4504-A9CE-7CCBE47142F0Q33995817-B82D0C9B-4BE5-4E53-8F10-621AE02DEB50Q34012336-CD6918D9-9E2E-499D-B90A-5818AEF292CBQ34334611-3AEA2077-8F76-4D17-A76D-CC1F05102F09Q34343391-6470F188-1952-4BC6-95B9-ACE5D48103D1Q34568354-6713E025-D864-4EAA-B5F1-E9F993A73699Q34589838-10171262-D9FA-41F7-A5A6-CBB5DBD804EAQ34603772-A0873554-86F2-4874-9BE7-923109457CB0Q34674473-BEB72194-DBBB-402B-AFDC-4B60DC827C1BQ34777926-32BDFC4B-3A97-4677-BFB3-B4FEE7BD3060Q35055415-9CE4350E-CA35-4302-A6C7-FE4E40DEA8A9Q35208686-F30C7B80-D534-48E9-A86D-59E8A17AD5A9Q35676180-09508561-0F5E-40EF-A9BC-D2C8D287086FQ35835849-01E00238-1185-4417-8C60-203DC550A2FCQ35919259-57BEB662-984C-4FA6-9A07-AB10CA1C4444Q36064989-64831DDA-08F2-4666-B6E3-1F73A12569FAQ36095172-9D7C329D-2B11-4B4D-AB9F-A867315D024FQ36125455-08E51413-A084-4FF4-A514-1E73A36E8F0AQ36366551-C7ADF77E-47C6-4E5F-8D93-4A088E34115FQ36545880-6C95F854-048E-43A5-9C99-3DD11275EDD7Q36607637-FEC9CBC4-DB4A-4875-B334-AED545310733Q36771100-B8E6B1A7-4E79-46AC-906A-D096C7099E75Q36794791-8887739A-EEAE-460A-9F87-D6FBA89D534A
P2860
Outpatient gatifloxacin therapy and dysglycemia in older adults
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Outpatient gatifloxacin therapy and dysglycemia in older adults
@ast
Outpatient gatifloxacin therapy and dysglycemia in older adults
@en
Outpatient gatifloxacin therapy and dysglycemia in older adults
@nl
type
label
Outpatient gatifloxacin therapy and dysglycemia in older adults
@ast
Outpatient gatifloxacin therapy and dysglycemia in older adults
@en
Outpatient gatifloxacin therapy and dysglycemia in older adults
@nl
prefLabel
Outpatient gatifloxacin therapy and dysglycemia in older adults
@ast
Outpatient gatifloxacin therapy and dysglycemia in older adults
@en
Outpatient gatifloxacin therapy and dysglycemia in older adults
@nl
P2093
P356
P1476
Outpatient gatifloxacin therapy and dysglycemia in older adults
@en
P2093
Alexander Kopp
Baiju R Shah
Carmine Stumpo
David N Juurlink
Laura Y Park-Wyllie
Linda Dresser
Muhammad M Mamdani
P304
P356
10.1056/NEJMOA055191
P407
P577
2006-03-01T00:00:00Z